SCHEDULE 13G/A: Millennium Entities Update Passive Stake in COMPASS Pathways plc

Millennium Management LLC and its affiliates have filed an amended Schedule 13G, updating their passive beneficial ownership in COMPASS Pathways plc as of December 31, 2024.

Summary

• Integrated Core Strategies (US) LLC reported beneficial ownership of 3,109,572 American Depositary Shares (ADS) of COMPASS Pathways plc, representing 3.4% of the class.
• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each reported beneficial ownership of 3,413,448 American Depositary Shares (ADS) of COMPASS Pathways plc, representing 3.7% of the class.
• The filing is an Amendment No. 1 to a previously filed Schedule 13G, indicating an update to their beneficial ownership position.
• The reporting persons, including Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, are filing as a group.
• The securities are American Depositary Shares, each representing one ordinary share, par value of GBP 0.008 per share.
• The beneficial ownership is passive, with the reporting persons certifying that the securities were not acquired for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing (Schedule 13G/A) updating beneficial ownership. It contains factual information about shareholdings and does not convey positive or negative sentiment regarding the company's performance or outlook.

Positives

• The continued disclosure of a significant stake by a major institutional investor group like Millennium Management may be viewed as a signal of ongoing interest in COMPASS Pathways plc.

Negatives

• The reported percentages (3.4% and 3.7%) are lower than the 5% threshold typically associated with initial 13G filings, suggesting a potential reduction in the group's overall stake from a previous filing, although the document states they 'remained beneficial owners of more than 5% of the outstanding ordinary shares' as a group.

Risks

• The document itself does not detail specific risks related to COMPASS Pathways plc's operations or financial health, as it is a beneficial ownership disclosure.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding COMPASS Pathways plc's future performance or strategic direction.

Industry Context

This filing reflects a routine update of a passive investment position by a prominent hedge fund group in COMPASS Pathways plc, a company operating in the biopharmaceutical sector, specifically known for its work in psychedelic-assisted therapies. Such disclosures provide transparency on institutional holdings but do not typically indicate strategic shifts for the issuer.

Corporate Governance

Related Party Transactions

• The reporting persons (Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander) are related entities under the Millennium group, with shared voting control and investment discretion over the reported securities.

Stakeholder Impact

• Shareholders: Provides transparency on a significant institutional investor's updated stake, which may influence investor perception or trading activity.
• Regulatory Authorities: Fulfills SEC disclosure requirements for beneficial ownership, ensuring market transparency.

Key Dates

Keywords

COMPASS Pathways plc, Millennium Management LLC, Integrated Core Strategies (US) LLC, Israel A. Englander, Schedule 13G/A, Beneficial Ownership, Institutional Investor, Equity Stake, ADS, Biotechnology